Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Frontiers in Neuroanatomy|April 27, 2017
Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory MechanismsLiliane Tenenbaum, Marie Humbert-ClaudeCurrent Gene Therapy|May 25, 2016
Tet-On Systems For Doxycycline-inducible Gene ExpressionAtze T Das, Liliane Tenenbaum, Ben BerkhoutJournal of Clinical Medicine|February 13, 2020
GDNF, A Neuron-Derived Factor Upregulated in Glial Cells during DiseaseMarcelo Duarte Azevedo, Sibilla Sander, Liliane TenenbaumCurrent Gene Therapy|November 8, 2013
Biosafety of recombinant adeno-associated virus vectorsDavid J Dismuke, Liliane Tenenbaum, R Jude SamulskiMethods in Molecular Biology (Clifton, N.J.)|October 29, 2011
Recombinant AAV delivery to the central nervous systemOlivier Bockstael, Kevin D Foust, Brian Kaspar, et al.Neurobiology of Disease|December 2, 2004
Clinical potential of minocycline for neurodegenerative disordersDavid Blum, Abdelwahed Chtarto, Liliane Tenenbaum, et al.Journal of Neuroscience Methods|March 2, 2021
Selective targeting of striatal parvalbumin-expressing interneurons for transgene deliveryMarcelo Duarte Azevedo, Sibilla Sander, Cheryl Jeanneret, et al.British Journal of Clinical Pharmacology|January 22, 2013
A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targetingAbdelwahed Chtarto, Olivier Bockstael, Terence Tshibangu, et al.Neurobiology of Disease|April 22, 2015
Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell developmentLayane Hanna-El-Daher, Elidie Béard, Hugues Henry, et al.Neuroscience Letters|November 20, 2003
Minocycline-induced activation of tetracycline-responsive promoterAbdelwahed Chtarto, Liliane Tenenbaum, Thierry Velu, et al.Pageof 4